{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:57:32Z","timestamp":1783191452389,"version":"3.54.6"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,8,30]]},"DOI":"10.18632\/oncotarget.10977","type":"journal-article","created":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T14:35:25Z","timestamp":1470062125000},"page":"57086-57098","source":"Crossref","is-referenced-by-count":19,"title":["Expression of the p66Shc protein adaptor is regulated by the activator of transcription STAT4 in normal and chronic lymphocytic leukemia B cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Francesca","family":"Cattaneo","sequence":"first","affiliation":[{"name":"Department of Life Sciences, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Patrussi","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaja","family":"Capitani","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Siena, Siena, Italy"},{"name":"Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Frezzato","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Milco","family":"D\u2019Elios","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Trentin","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpietro","family":"Semenzato","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Padua, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosima T.","family":"Baldari","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(92)90536-L","article-title":"A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction","volume":"70","author":"Pelicci","year":"1992","journal-title":"Cell"},{"key":"2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/emboj\/16.4.706","article-title":"Opposite effects of the p52shc\/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway","volume":"16","author":"Pelicci","year":"1997","journal-title":"EMBO J"},{"key":"3","doi-asserted-by":"crossref","first-page":"28042","DOI":"10.1074\/jbc.272.44.28042","article-title":"The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway","volume":"272","author":"Pessin","year":"1997","journal-title":"J Biol Chem"},{"key":"4","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/MCB.24.4.1747-1757.2004","article-title":"p66SHC promotes apoptosis and antagonizes mitogenic signaling in T cells","volume":"24","author":"Baldari","year":"2004","journal-title":"Mol Cell Biol"},{"key":"5","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.1182\/blood-2007-12-130856","article-title":"The proapoptotic and antimitogenic protein p66SHC acts as a negative regulator of lymphocyte activation and autoimmunity","volume":"111","author":"Baldari","year":"2008","journal-title":"Blood"},{"key":"6","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1182\/blood-2009-08-239244","article-title":"Impaired expression of p66Shc a novel regulator of B-cell survival in chronic lymphocytic leukemia","volume":"115","author":"Baldari","year":"2010","journal-title":"Blood"},{"key":"7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/46311","article-title":"The p66shc adaptor protein controls oxidative stress response and life span in mammals","volume":"402","author":"Pelicci","year":"1999","journal-title":"Nature"},{"key":"8","doi-asserted-by":"publisher","first-page":"22370","DOI":"10.1074\/jbc.M200280200","article-title":"The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter","volume":"277","author":"Pelicci","year":"2002","journal-title":"J Biol Chem"},{"key":"9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbrc.2006.08.039","article-title":"Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylation","volume":"349","author":"Baldari","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1091\/mbc.E13-11-0666","article-title":"Evidence for a novel antioxidant function and isoform-specific regulation of the human p66Shc gene","volume":"25","author":"Tsuji","year":"2014","journal-title":"Mol Biol Cell"},{"key":"11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.canlet.2013.05.016","article-title":"Feedback loop between p66(Shc) and Nrf2 promotes lung cancer progression","volume":"337","author":"Liu","year":"2013","journal-title":"Cancer Lett"},{"key":"12","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1182\/blood-2012-04-425959","article-title":"S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis","volume":"120","author":"Baldari","year":"2012","journal-title":"Blood"},{"key":"13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0092-8674(80)90237-8","article-title":"Cellular differentiation cytidine analogs and DNA methylation","volume":"20","author":"Taylor","year":"1980","journal-title":"Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.4049\/jimmunol.172.11.6775","article-title":"Early target genes of IL-12 and STAT4 signaling in th cells","volume":"172","author":"Lahesmaa","year":"2004","journal-title":"J Immunol"},{"key":"15","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1182\/blood-2008-09-179820","article-title":"Impaired development of human Th1 cells in patients with deficient expression of STAT4","volume":"113","author":"Kaplan","year":"2009","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/intimm\/dxh034","article-title":"A mechanism underlying STAT4-mediated up-regulation of IFN-gamma induction inTCR-triggered T cells","volume":"16","author":"Fujiwara","year":"2004","journal-title":"Int Immunol"},{"key":"17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1126\/science.1074900","article-title":"Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection","volume":"297","author":"Biron","year":"2002","journal-title":"Science"},{"key":"18","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.4049\/jimmunol.0803450","article-title":"IL-7 receptor expression provides the potential for long-term survival of both CD62Lhigh central memory T cells and Th1 effector cells during Leishmania major infection","volume":"182","author":"Scott","year":"2009","journal-title":"J Immunol"},{"key":"19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/gene.2008.20","article-title":"Stat4-dependent T-bet-independent regulation of IL-10 in NK cells","volume":"9","author":"Bream","year":"2008","journal-title":"Genes Immun"},{"key":"20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4049\/jimmunol.1302734","article-title":"IL-1beta promotes the differentiation of polyfunctional human CCR6+CXCR3+ Th1\/17 cells that are specific for pathogenic and commensal microbes","volume":"193","author":"Campbell","year":"2014","journal-title":"J Immunol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.4049\/jimmunol.165.4.1933","article-title":"IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells","volume":"165","author":"Matikainen","year":"2000","journal-title":"J Immunol"},{"key":"22","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/382174a0","article-title":"Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice","volume":"382","author":"Grusby","year":"1996","journal-title":"Nature"},{"key":"23","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/cvr\/cvr250","article-title":"Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc","volume":"92","author":"Irani","year":"2011","journal-title":"Cardiovasc Res"},{"key":"24","first-page":"3267","article-title":"Epigenetic modifiers exert renal toxicity through induction of p66shc","volume":"31","author":"Juncos","year":"2011","journal-title":"Anticancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tox.2010.07.011","article-title":"Epigenetic enhancement of p66Shc during cellular replicative or premature senescence","volume":"278","author":"Zhuang","year":"2010","journal-title":"Toxicology"},{"key":"26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Darnell","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"27","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1006\/bbrc.1998.9693","article-title":"Interleukin-12 Expression in B Cells by Transformation with Epstein-Barr Virus","volume":"252","author":"Nariuchi","year":"1998","journal-title":"Biochem Bioph Res Commun"},{"key":"28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"Jaks and STATs: biological implications","volume":"16","author":"O'shea","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"29","doi-asserted-by":"publisher","first-page":"902","DOI":"10.4049\/jimmunol.1203229","article-title":"Opposing roles of STAT4 and Dnmt3a in Th1 gene regulation","volume":"191","author":"Kaplan","year":"2013","journal-title":"J Immunol"},{"key":"30","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1182\/blood-2011-06-338855","article-title":"B-cell receptor signaling in chronic lymphocytic leukemia","volume":"118","author":"Packham","year":"2011","journal-title":"Blood"},{"key":"31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Bernardi","year":"2005","journal-title":"Cell"},{"key":"32","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.semcancer.2010.09.005","article-title":"Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting","volume":"20","author":"Burger","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"33","first-page":"4497","article-title":"The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response","volume":"63","author":"Foa","year":"2003","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/sji.12172","article-title":"High functional CD70 expression on alpha-type 1-polarized dendritic cells from patients with chronic lymphocytic leukaemia","volume":"79","author":"Andersson","year":"2014","journal-title":"Scand J Immunol"},{"key":"35","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1172\/JCI35017","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Gribben","year":"2008","journal-title":"J Clin Invest"},{"key":"36","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/1042819031000068007","article-title":"IL-4 biology: impact on normal and leukemic CLL B cells","volume":"44","author":"Pittner","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"37","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.beha.2007.03.006","article-title":"Gene therapy and active immune therapy of hematologic malignancies","volume":"20","author":"Kipps","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"38","first-page":"767","article-title":"The aminoterminal phosphotyrosine binding domain of Shc associates with ZAP-70 and mediates TCR dependent gene activation","volume":"13","author":"Baldari","year":"1996","journal-title":"Oncogene"},{"key":"39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1006\/bbrc.2001.6023","article-title":"Analysis of chromatin-immunopurified MeCP2-associated fragments","volume":"289","author":"Wolffe","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/prot.21786","article-title":"Combining the polymerase incomplete primer extension method for cloning and mutagenesis with microscreening to accelerate structural genomics efforts","volume":"71","author":"Lesley","year":"2008","journal-title":"Proteins"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T16:20:26Z","timestamp":1594830026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.10977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":40,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2016,8,30]]}},"alternative-id":["10977","27494881"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.10977","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,1]]}}}